FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to molecular biology and genetic engineering. What is declared is a genetically modified mesenchymal stem cell for the selective expression of cytotoxic protein containing exogenous nucleic acid comprising a region coding cytotoxic protein and functionally bound to a promoter or a combination of promoter/enhancer, wherein the promoter or the combination of promoter/enhancer cause the selective expression of cytotoxic protein, when the genetically modified mesenchymal stem cell closes the stromal tumour tissue.
EFFECT: what is declared is the genetically modified mesenchymal stem cell for the selective expression of cytotoxic protein.
30 cl, 10 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR GENE THERAPY OF MALIGNANT GROWTHS | 2010 |
|
RU2447150C1 |
| MULTI-PURPOSE PROMOTER, EXPRESSION VECTOR, AND METHOD OF SELECTIVE KILLING CANCER CELLS WITH THEIR USE | 2012 |
|
RU2476596C1 |
| METHOD OF USING STEM CELLS IN TISSUE REPLACEMENT THERAPY | 2009 |
|
RU2422514C1 |
| METHODS AND COMPONENTS FOR INDUCTION OF TUMOR- -SPECIFIC CYTOTOXICITY | 1998 |
|
RU2214280C2 |
| CHIMERIC ANTIGENIC RECEPTORS WITH MND-PROMOTER | 2015 |
|
RU2708311C2 |
| CHIMERIC ANTIGENIC RECEPTORS WITH MND PROMOTER | 2015 |
|
RU2799573C2 |
| PROMOTER FOR TISSUE-SPECIFIC GENE EXPRESSION IN TERMINAL MAMMAL TISSUES | 2010 |
|
RU2459870C2 |
| METHOD OF PROVIDING SAFETY OF APPLICATION OF PLURIPOTENT STEM CELLS IN TISSUE-SUBSTITUTING THERAPY BY MEANS OF ARTIFICIAL CHROMOSOMES | 2012 |
|
RU2548819C2 |
| MULTIPURPOSE CANCER-SPECIFIC PROMOTERS AND USING THEM IN ANTI-CANCER THERAPY | 2013 |
|
RU2539764C2 |
| RETROVIRAL VECTORS TRANSDUCING CYTOCHROME P450 | 1997 |
|
RU2185821C2 |
